Capital International, Inc. Legend Biotech Corp Transaction History

Capital International, Inc.

$7.57 Billion
Q3 2024

A detailed history of Capital International, Inc. transactions in Legend Biotech Corp stock. As of the latest transaction made, Capital International, Inc. holds 570,512 shares of LEGN stock, worth $24.4 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares

570,512

Previous 531,660 7.31%

Holding current value

$24.4 Million

Previous $23.5 Million 18.07%

% of portfolio

0.37%

Previous 0.33%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$43.55 - $59.88 $1.69 Million - $2.33 Million	38,852 Added 7.31%	570,512 $27.8 Million
Q2 2024 Aug 13, 2024	BUY	$39.5 - $57.22 $3.08 Million - $4.46 Million	77,996 Added 17.19%	531,660 $23.5 Million
Q1 2024 May 14, 2024	BUY	$55.06 - $69.99 $1.18 Million - $1.5 Million	21,448 Added 4.96%	453,664 $25.4 Million
Q4 2023 Feb 13, 2024	SELL	$57.25 - $69.74 $1.65 Million - $2.01 Million	-28,820 Reduced 6.25%	432,216 $26 Million
Q3 2023 Nov 13, 2023	SELL	$63.16 - $76.5 $1.75 Million - $2.12 Million	-27,721 Reduced 5.67%	461,036 $31 Million
Q2 2023 Aug 11, 2023	SELL	$46.28 - $75.01 $729,511 - $1.18 Million	-15,763 Reduced 3.12%	488,757 $33.7 Million
Q1 2023 May 15, 2023	SELL	$43.42 - $57.37 $2.45 Million - $3.23 Million	-56,357 Reduced 10.05%	504,520 $24.3 Million
Q4 2022 Feb 14, 2023	SELL	$38.8 - $55.46 $26.5 Million - $37.9 Million	-683,485 Reduced 54.93%	560,877 $28 Million
Q3 2022 Nov 14, 2022	BUY	$38.15 - $57.1 $301,041 - $450,576	7,891 Added 0.64%	1,244,362 $50.8 Million
Q2 2022 Aug 15, 2022	SELL	$33.54 - $55.0 $17.7 Million - $29 Million	-526,619 Reduced 29.87%	1,236,471 $68 Million
Q1 2022 May 16, 2022	SELL	$31.02 - $48.18 $5.6 Million - $8.7 Million	-180,627 Reduced 9.29%	1,763,090 $64.1 Million
Q4 2021 Feb 14, 2022	BUY	$41.14 - $56.98 $981,230 - $1.36 Million	23,851 Added 1.24%	1,943,717 $90.6 Million
Q3 2021 Nov 15, 2021	SELL	$35.31 - $50.56 $1.13 Million - $1.62 Million	-31,979 Reduced 1.64%	1,919,866 $97.1 Million
Q2 2021 Aug 16, 2021	BUY	$25.8 - $41.09 $903,000 - $1.44 Million	35,000 Added 1.83%	1,951,845 $80.1 Million
Q4 2020 Feb 16, 2021	SELL	$25.8 - $32.39 $2.63 Million - $3.31 Million	-102,111 Reduced 5.06%	1,916,845 $54 Million
Q2 2020 Aug 14, 2020	BUY	$36.1 - $42.56 $72.9 Million - $85.9 Million	2,018,956 New	2,018,956 $85.9 Million

Others Institutions Holding LEGN

# of Institutions

225

Shares Held

74.3M

Call Options Held

279K

Put Options Held

350K

View Full List

About Legend Biotech Corp

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $7.15B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

More about LEGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Capital International, Inc. with notifications on news.

Account

Capital International, Inc. Legend Biotech Corp Transaction History